JPH01144983A - Production of unsaturated hydrocarbon and derivative thereof - Google Patents
Production of unsaturated hydrocarbon and derivative thereofInfo
- Publication number
- JPH01144983A JPH01144983A JP30005887A JP30005887A JPH01144983A JP H01144983 A JPH01144983 A JP H01144983A JP 30005887 A JP30005887 A JP 30005887A JP 30005887 A JP30005887 A JP 30005887A JP H01144983 A JPH01144983 A JP H01144983A
- Authority
- JP
- Japan
- Prior art keywords
- cells
- derivatives
- chloro
- acid
- inorganic metal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229930195735 unsaturated hydrocarbon Natural products 0.000 title claims abstract description 27
- 238000004519 manufacturing process Methods 0.000 title claims description 13
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 11
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims abstract description 11
- 241000316848 Rhodococcus <scale insect> Species 0.000 claims abstract description 11
- 229910052751 metal Inorganic materials 0.000 claims abstract description 11
- 239000002184 metal Substances 0.000 claims abstract description 11
- 229940024606 amino acid Drugs 0.000 claims abstract description 10
- 150000001413 amino acids Chemical class 0.000 claims abstract description 10
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 10
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019157 thiamine Nutrition 0.000 claims abstract description 7
- 239000011721 thiamine Substances 0.000 claims abstract description 7
- 229960002989 glutamic acid Drugs 0.000 claims abstract description 6
- 229960003495 thiamine Drugs 0.000 claims abstract description 6
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims abstract description 6
- 241000187562 Rhodococcus sp. Species 0.000 claims abstract description 4
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims abstract description 3
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 claims abstract 3
- 229940094933 n-dodecane Drugs 0.000 claims abstract 2
- GQEZCXVZFLOKMC-UHFFFAOYSA-N 1-hexadecene Chemical compound CCCCCCCCCCCCCCC=C GQEZCXVZFLOKMC-UHFFFAOYSA-N 0.000 claims description 12
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 claims description 8
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 claims description 6
- CLWAXFZCVYJLLM-UHFFFAOYSA-N 1-chlorohexadecane Chemical compound CCCCCCCCCCCCCCCCCl CLWAXFZCVYJLLM-UHFFFAOYSA-N 0.000 claims description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 4
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- 229960005261 aspartic acid Drugs 0.000 claims description 3
- ZXPWFWWSCFIFII-UHFFFAOYSA-N heptadecanenitrile Chemical compound CCCCCCCCCCCCCCCCC#N ZXPWFWWSCFIFII-UHFFFAOYSA-N 0.000 claims description 3
- 229940095068 tetradecene Drugs 0.000 claims description 3
- 229960004441 tyrosine Drugs 0.000 claims description 3
- VUQPJRPDRDVQMN-UHFFFAOYSA-N 1-chlorooctadecane Chemical compound CCCCCCCCCCCCCCCCCCCl VUQPJRPDRDVQMN-UHFFFAOYSA-N 0.000 claims description 2
- 239000004471 Glycine Substances 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- 229930182821 L-proline Natural products 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 229910052748 manganese Inorganic materials 0.000 claims description 2
- 239000011572 manganese Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- CCCMONHAUSKTEQ-UHFFFAOYSA-N octadecene Natural products CCCCCCCCCCCCCCCCC=C CCCMONHAUSKTEQ-UHFFFAOYSA-N 0.000 claims description 2
- 229960002429 proline Drugs 0.000 claims description 2
- 229960002898 threonine Drugs 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- YCOZIPAWZNQLMR-UHFFFAOYSA-N heptane - octane Natural products CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 claims 3
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims 2
- NDJKXXJCMXVBJW-UHFFFAOYSA-N heptadecane Chemical compound CCCCCCCCCCCCCCCCC NDJKXXJCMXVBJW-UHFFFAOYSA-N 0.000 claims 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 claims 2
- FGIOHOBVUCNHBY-UHFFFAOYSA-N 1-chloroheptadecane Chemical compound CCCCCCCCCCCCCCCCCCl FGIOHOBVUCNHBY-UHFFFAOYSA-N 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- 229930182844 L-isoleucine Natural products 0.000 claims 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
- 229960002449 glycine Drugs 0.000 claims 1
- DEQLTFPCJRGSHW-UHFFFAOYSA-N hexadecylbenzene Chemical compound CCCCCCCCCCCCCCCCC1=CC=CC=C1 DEQLTFPCJRGSHW-UHFFFAOYSA-N 0.000 claims 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 1
- 229960000367 inositol Drugs 0.000 claims 1
- 229960000310 isoleucine Drugs 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 abstract description 18
- 229910052943 magnesium sulfate Inorganic materials 0.000 abstract description 10
- 235000019341 magnesium sulphate Nutrition 0.000 abstract description 9
- 244000005700 microbiome Species 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000003016 pheromone Substances 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 24
- 239000002609 medium Substances 0.000 description 24
- 239000000243 solution Substances 0.000 description 19
- 229920001817 Agar Polymers 0.000 description 15
- 239000008272 agar Substances 0.000 description 15
- 239000008363 phosphate buffer Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 9
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000004817 gas chromatography Methods 0.000 description 8
- 229960000344 thiamine hydrochloride Drugs 0.000 description 8
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 8
- 239000011747 thiamine hydrochloride Substances 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000007853 buffer solution Substances 0.000 description 5
- 229940077731 carbohydrate nutrients Drugs 0.000 description 5
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- -1 hexadecylbenzene (hexa decylbenzene) Chemical compound 0.000 description 5
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 5
- 230000001766 physiological effect Effects 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 4
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- SRITYGSDILBHBS-UHFFFAOYSA-N 1-chlorohexadec-1-ene Chemical compound CCCCCCCCCCCCCCC=CCl SRITYGSDILBHBS-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229940099596 manganese sulfate Drugs 0.000 description 3
- 235000007079 manganese sulphate Nutrition 0.000 description 3
- 239000011702 manganese sulphate Substances 0.000 description 3
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 229930014626 natural product Natural products 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 239000012138 yeast extract Substances 0.000 description 3
- PJLHTVIBELQURV-UHFFFAOYSA-N 1-pentadecene Chemical compound CCCCCCCCCCCCCC=C PJLHTVIBELQURV-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 125000000350 glycoloyl group Chemical group O=C([*])C([H])([H])O[H] 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- FNJOJJWNIKUCMT-FNORWQNLSA-N (3e)-hexadeca-1,3-diene Chemical compound CCCCCCCCCCCC\C=C\C=C FNJOJJWNIKUCMT-FNORWQNLSA-N 0.000 description 1
- LRIUTQPZISVIHK-FNORWQNLSA-N (3e)-tetradeca-1,3-diene Chemical compound CCCCCCCCCC\C=C\C=C LRIUTQPZISVIHK-FNORWQNLSA-N 0.000 description 1
- JZPUSPPFVAJNGY-FYWRMAATSA-N (e)-hexadec-7-ene Chemical compound CCCCCCCC\C=C\CCCCCC JZPUSPPFVAJNGY-FYWRMAATSA-N 0.000 description 1
- JZPUSPPFVAJNGY-SQFISAMPSA-N (z)-hexadec-7-ene Chemical compound CCCCCCCC\C=C/CCCCCC JZPUSPPFVAJNGY-SQFISAMPSA-N 0.000 description 1
- AFGNVSCTEXUEJE-UHFFFAOYSA-N 1-chloroicosane Chemical compound CCCCCCCCCCCCCCCCCCCCCl AFGNVSCTEXUEJE-UHFFFAOYSA-N 0.000 description 1
- RNHWYOLIEJIAMV-UHFFFAOYSA-N 1-chlorotetradecane Chemical compound CCCCCCCCCCCCCCCl RNHWYOLIEJIAMV-UHFFFAOYSA-N 0.000 description 1
- HYPYXGZDOYTYDR-HAJWAVTHSA-N 2-methyl-3-[(2e,6e,10e,14e)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaenyl]naphthalene-1,4-dione Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)=C(C)C(=O)C2=C1 HYPYXGZDOYTYDR-HAJWAVTHSA-N 0.000 description 1
- KYARBIJYVGJZLB-UHFFFAOYSA-N 7-amino-4-hydroxy-2-naphthalenesulfonic acid Chemical compound OC1=CC(S(O)(=O)=O)=CC2=CC(N)=CC=C21 KYARBIJYVGJZLB-UHFFFAOYSA-N 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- PAEASVRMKPAASA-UHFFFAOYSA-N hexadec-1-ene Chemical compound CCCCCCCCCCCCCCC=C.CCCCCCCCCCCCCCC=C PAEASVRMKPAASA-UHFFFAOYSA-N 0.000 description 1
- ABIOZVCSOXRLLF-UHFFFAOYSA-N hexadec-1-enylbenzene Chemical compound CCCCCCCCCCCCCCC=CC1=CC=CC=C1 ABIOZVCSOXRLLF-UHFFFAOYSA-N 0.000 description 1
- FNJOJJWNIKUCMT-UHFFFAOYSA-N hexadeca-1,3-diene Chemical compound CCCCCCCCCCCCC=CC=C FNJOJJWNIKUCMT-UHFFFAOYSA-N 0.000 description 1
- VOJREVRIHQPQTJ-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCO VOJREVRIHQPQTJ-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WJNTYZBOAZPASI-UHFFFAOYSA-N icos-1-ene Chemical compound CCCCCCCCCCCCCCCCCCC=C.CCCCCCCCCCCCCCCCCCC=C WJNTYZBOAZPASI-UHFFFAOYSA-N 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- JFOHGHXDQDZWLH-UHFFFAOYSA-N octadec-1-ene Chemical compound CCCCCCCCCCCCCCCCC=C.CCCCCCCCCCCCCCCCC=C JFOHGHXDQDZWLH-UHFFFAOYSA-N 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WTWSHHITWMVLBX-DKWTVANSSA-M sodium;(2s)-2-aminobutanedioate;hydron Chemical compound [Na+].[O-]C(=O)[C@@H](N)CC(O)=O WTWSHHITWMVLBX-DKWTVANSSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 235000019143 vitamin K2 Nutrition 0.000 description 1
- 239000011728 vitamin K2 Substances 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野)
本発明は微生物を用いる不飽和炭化水素およびその誘導
体の製造法に関する。DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to a method for producing unsaturated hydrocarbons and derivatives thereof using microorganisms.
〔従来の技術およびその問題点]
不飽和炭化水素およびその誘導体は、フェロモン、香料
、薬剤として、またこれらの合成原料、あるいは有機化
合物の合成中間体として広く使用されている。[Prior Art and its Problems] Unsaturated hydrocarbons and their derivatives are widely used as pheromones, fragrances, and drugs, as raw materials for their synthesis, or as intermediates for the synthesis of organic compounds.
従来、斯かる不飽和炭化水素およびその誘導体は、メタ
セシス反応を利用した化学合成による方法が知られてい
る。Conventionally, such unsaturated hydrocarbons and their derivatives have been known to be chemically synthesized using metathesis reactions.
しかし、化学合成では多工程を要すると共に、シス体と
トランス体の立体異性体が混合状態で得られるという欠
点があった。However, chemical synthesis requires multiple steps and has the disadvantage that cis and trans stereoisomers are obtained in a mixed state.
一方、アルケン製造において微生物を利用する方法とし
ては、ノカルデイア(Nocardia)属菌を用いる
方法(米国特許第3629072号)があるが、収量が
低く、反応時間も長いという欠点があ素を製造する方法
を報告したが、該方法を用いた場合、生産量が未だ十分
とはいえず、工業的生産性を十分に満足するものとはい
えなかった。On the other hand, as a method of using microorganisms in the production of alkenes, there is a method of using bacteria of the genus Nocardia (US Pat. No. 3,629,072), but this method has the disadvantages of low yield and long reaction time. However, when this method was used, the production volume was still not sufficient and it could not be said that industrial productivity was fully satisfied.
また、工業的に入手容易なモノアルケンからジアルケン
を製造する簡便な方法が望まれているが、この要求を満
たす方法は未だ確立されていないのが現状である。Furthermore, although there is a desire for a simple method for producing dialkenes from industrially easily available monoalkenes, no method has yet been established that satisfies this requirement.
C問題点を解決するための手段〕
斯かる現状において、本発明者らは鋭意研究を行った結
果、沖縄系の土壌から分離し、さらに参考例1に示すよ
うな変異操作により得られた微生物が炭化水素を不飽和
炭化水素およびその誘導体に変換する能力を有すること
、ならびに生産された不飽和炭化水素およびその誘導体
は菌体外に排出され、容易に回収できることを見出した
。さらには、本菌株の菌体反応により高収量で不飽和炭
化水素およびその誘導体を製造する方法、すなわち、菌
体と基質である炭化水素またはその誘導体より成る反応
液に、L−グルタミン酸、L−アス実を見出し本発明を
完成した。Means for Solving Problem C] Under the current situation, the present inventors conducted intensive research and found that microorganisms isolated from Okinawan soil and further obtained through mutational manipulation as shown in Reference Example 1. It was discovered that the microorganism has the ability to convert hydrocarbons into unsaturated hydrocarbons and their derivatives, and that the produced unsaturated hydrocarbons and their derivatives are excreted outside the microbial cell and can be easily recovered. Furthermore, we have developed a method for producing unsaturated hydrocarbons and their derivatives in high yields through cell reactions using this strain, in which L-glutamic acid, L-glutamic acid, L- He discovered the Aspergillus japonica and completed the present invention.
すなわち、本発明は、ロドコッカス属に属する不飽和炭
化水素生産菌の菌体を用い、炭水化物もしくはアミノ酸
存在下に、炭化水素またはその誘導体を該菌体に作用せ
しめ不飽和炭化水素またはその誘導体を製造するに際し
、系内にチアミンまたは無機金属塩を存在させることを
特徴とする不飽和炭化水素およびその誘導体の製造法を
提供するものである。That is, the present invention uses cells of an unsaturated hydrocarbon-producing bacterium belonging to the genus Rhodococcus, and allows hydrocarbons or derivatives thereof to act on the cells in the presence of carbohydrates or amino acids to produce unsaturated hydrocarbons or derivatives thereof. The present invention provides a method for producing unsaturated hydrocarbons and derivatives thereof, characterized in that thiamine or an inorganic metal salt is present in the system.
本発明者らが見出した本発明で使用されるロドコッカス
属に属する不飽和炭化水素生産菌は、参考例1の方法で
沖縄系の土壌より取得した菌株を変異により育種した株
であり、次の菌学的性質を有する。The unsaturated hydrocarbon-producing bacterium belonging to the genus Rhodococcus discovered by the present inventors and used in the present invention is a strain bred by mutation of a strain obtained from Okinawan soil by the method of Reference Example 1. It has mycological properties.
(A)形態
桿菌で、細胞は多形性で、若い培養では桿菌状、古い培
養では球状となる。大きさは0.5〜0.8 u m
Xl、O〜5.Ott mである。(A) Morphology: Bacilli; the cells are pleomorphic, becoming rod-shaped in young cultures and spherical in older cultures. Size is 0.5~0.8 um
Xl, O~5. Ott m.
(B)各培地における生育状態
生育は貧弱であり、コロニーの色は淡い肌色で、滑らか
で光沢がある。(B) Growth status in each medium Growth is poor, colonies are pale flesh-colored, smooth and shiny.
■グリセリン・アスパラギン寒天培地
生育は中程度であり、コロニーの色は乳白色で、滑らか
でにぷい光沢がある。スムーズとラフなコロニーが見ら
れる。■Glycerin-asparagine agar medium Growth is moderate, and the colonies are milky-white, smooth and glossy. Smooth and rough colonies can be seen.
■スターチ寒天培地
生育は中程度であり、コロニーの色は乳白色で、滑らか
でにぷい光沢がある。■Growth on starch agar medium is moderate, and the colonies are milky-white, smooth and glossy.
■チロシン寒天培地
生育は旺盛で、コロニーの色は肌色で、滑らかで光沢が
ある。スライム状になるコロニーが見られる。■Tyrosine agar medium Growth is vigorous, and the colonies are flesh-colored, smooth and shiny. Colonies that become slime-like can be seen.
■栄養寒天培地
生育は旺盛で、コロニーの色は淡いオレンジ色で、滑ら
かで光沢がある。スムーズとラフなコロニーが見られる
。■Nutritional agar medium Growth is vigorous, and the colonies are pale orange in color, smooth and glossy. Smooth and rough colonies can be seen.
■イースト・麦芽寒天培地
生育は旺盛で、コロニーの色はオレンジ色で、ンジ色で
、にぶい光沢がある。■Yeast/malt agar medium Growth is vigorous, and colonies are orange to dark brown with a dull luster.
(C)生理学的性質
■生育範囲
温度:15〜37°C(最適25〜35°C)p H:
5〜9.5(最適6〜8)
■ゼラチンの液化(グルコース・ペプトン・ゼラチン培
地)
陰性。(C) Physiological properties ■Growth range Temperature: 15-37°C (optimal 25-35°C) pH:
5-9.5 (optimal 6-8) ■ Liquefaction of gelatin (glucose/peptone/gelatin medium) Negative.
■スターチの加水分解(スターチ寒天培地)陰性。■Starch hydrolysis (starch agar medium) negative.
■脱脂牛乳の凝固、ペプトン化 共に陰性。■Coagulation and peptonization of skimmed milk Both tested negative.
■メラニン様色素の生成(チロシン培地、ペプトン・イ
ースト・鉄培地)
陰性。■Melanin-like pigment production (tyrosine medium, peptone/yeast/iron medium) Negative.
(D)炭素源の資化性 ■L−アラビノース + ■D−キシロース + ■D−グルコース + ■D−マンニトール + (E)化学分類学的性質 ■グリコリルテスト グリコリル型。(D) Assimilation of carbon sources ■L-arabinose + ■D-xylose + ■D-glucose + ■D-Mannitol + (E) Chemotaxonomic properties ■Glycolyl test Glycolyl type.
■メナキノン システム
MK8(Hz)−
以上の菌学的性質を有する微生物について、バーシーズ
・マニュアル・オブ・システマテインク・バタテリオロ
ジー(Bergey’s Manual ofSyst
ematic Bacteriology)+第2巻(
1986年)に基づき検索した結果、ロドコッカス(R
hodococcus)属に属する菌株と認められたが
、他のロドコッカス属菌と不飽和炭化水素の生産性の生
産性が著しく異なるため、ロドコッカス・エスピー・K
SM−B −3M (Rhodococcus sp、
K S M −B −3M)と命名し、通産省工業
技術院微生物工業技術研究所に微工研条寄第1531号
(FERM BP−1531)として寄託しである。■ Menaquinone System MK8 (Hz) - Regarding microorganisms with the above mycological properties, please refer to Bergey's Manual of Syst
ematic Bacteriology) + Volume 2 (
As a result of the search based on Rhodococcus (1986), Rhodococcus (R
Although it was recognized as a strain belonging to the genus Rhodococcus, the productivity of unsaturated hydrocarbons is significantly different from that of other Rhodococcus bacteria, so Rhodococcus sp.
SM-B-3M (Rhodococcus sp,
K S M -B -3M) and has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology, Ministry of International Trade and Industry, as FERM BP-1531.
本発明の原料の炭化水素およびその誘導体とし〔式中R
は炭素数6〜22の直鎖もしくは分岐、飽和もしくは不
飽和の炭化水素基を表し、Aは水素原子、芳香族炭化水
素基、ハロゲン原子、−0H1−CN、−CO−R,(
R,は炭素数1〜10の直鎖もしくは分岐炭化水素基あ
るいは芳香族炭化水素基を表す)、 o R2(Rz
は炭素数1〜10の直鎖もしくは分岐炭化水素基ある
いは芳香族炭化水素基を表す)、金属または、(Rff
、R4は水素原子、もしくは炭素数1〜5の直鎖もし
くは分岐炭化水素基を示す)で表される基を表す。〕
本発明においては、Rが炭素数14〜20の直鎖の炭化
水素のものが好ましく用いられる。Hydrocarbons and derivatives thereof as raw materials of the present invention [in the formula R
represents a straight chain or branched, saturated or unsaturated hydrocarbon group having 6 to 22 carbon atoms, and A is a hydrogen atom, an aromatic hydrocarbon group, a halogen atom, -0H1-CN, -CO-R, (
R represents a straight chain or branched hydrocarbon group or an aromatic hydrocarbon group having 1 to 10 carbon atoms), o R2 (Rz
represents a linear or branched hydrocarbon group or an aromatic hydrocarbon group having 1 to 10 carbon atoms), a metal or (Rff
, R4 represents a hydrogen atom or a straight chain or branched hydrocarbon group having 1 to 5 carbon atoms. ] In the present invention, those in which R is a straight chain hydrocarbon having 14 to 20 carbon atoms are preferably used.
そして本発明によれば、上記炭化水素およびその誘導体
は、対応する不飽和炭化水素およびそのデカン(pen
tadecane) 、エイコサン(eicosane
)、クロロ−ヘキサデカン(chloro−hexad
ecane)、クロロ−オクタデカン(chloro−
octadeeane)、ヘキサデカノール(hexa
decanol) 、ヘキサデシルベンゼン(hexa
decylbenzene)、ヘプタデカノニトリル(
heptadecanonitorile)、ヘキサデ
セン(hexa−decene) 、エイコセン(ei
cosene)、テトラデセン(te tradece
ne)等の炭化水素及びその誘導体からは、それぞれ、
ヘキサデセン(hexadecene) 、オクタデセ
ン(octadecene)、テトラデセン(tetr
ade−cene) 、ペンタデセン(pentade
cene) 、エイコセン(eicosene)、クロ
ロ−へキサデセン(chloro−hexadecen
e) 、クロロ−オクタデセン(chloro−oct
adecene) 、ヘキサデカジエン(hexade
cenol)、ヘキサデセニルベンゼン(hexade
cenylbenzene)、ヘブタデセノニトリル(
heptadecenoni torile)、ヘキサ
デカジエン(hexadeca−di−ene)、エイ
コサジエン(eicosa−di−ene) 、テトラ
デカジエン(tetradeca−di−ene)等が
生産される。According to the invention, the hydrocarbons and their derivatives are the corresponding unsaturated hydrocarbons and their decane
tadecane), eicosane
), chloro-hexadecane (chloro-hexad
ecane), chloro-octadecane (chloro-
octadeane), hexadecanol (hexa
decanol), hexadecylbenzene (hexa
decylbenzene), heptadecanonitrile (
heptadecanonitrile), hexadecene (hexa-decene), eicosene (ei
cosene), tetradecene (te tradece)
From hydrocarbons such as ne) and their derivatives, respectively,
hexadecene, octadecene, tetradecene
ade-cene), pentadecene
cene), eicosene, chloro-hexadecene
e) , chloro-octadecene (chloro-octadecene)
adecene), hexadecadiene (hexade)
cenol), hexadecenylbenzene (hexade
cenylbenzene), hebutadecenonitrile (
Heptadecenoni torile, hexadeca-di-ene, eicosa-di-ene, tetradecadiene, etc. are produced.
本発明において、用いる菌体を取得するには通い。好ま
しくは、30℃で1〜2日間、好気的に培養する。In the present invention, the microbial cells to be used are obtained through regular use. Preferably, the culture is carried out aerobically at 30°C for 1 to 2 days.
かくして得られた、培養液をそのまま、あるいは遠心分
離または濾過等により菌体を取得し以下の反応に供する
。The culture fluid thus obtained is used as it is, or the bacterial cells are obtained by centrifugation, filtration, etc. and subjected to the following reaction.
菌体を用いる反応液の調製、ならびに反応は以下のごと
く行う。Preparation of a reaction solution using bacterial cells and reaction are performed as follows.
上記の培養液または集めた菌体を0.1〜90%、好ま
しくは菌体乾燥重量として0.2〜0.5%を水あるい
は緩衝液(pH6〜8)に懸濁し、反応させる炭化水素
及びその誘導体を1〜70%、好ましくは10〜30%
、L−グルタミン酸、L−アスパラギン酸等のアミノ酸
または、ぶどう糖、クエン酸等の炭水化物を0.05〜
10%、好ましくは0.5〜2%を含有するものを基本
反応液とし、さらに、チアミンの塩酸塩等を0.001
〜2%、好ましくはチアミン含量として0.01〜0.
3%、または硫酸マグネシウム、硫酸マンガン等の無機
金属塩を0.001〜添加は、不飽和炭化水素およびそ
の誘導体の生産性を大幅に向上させるためであり、L−
グルタミン酸、L−アスパラギン酸等のアミノ酸との組
合せが好ましいが、他の炭水化物との組合せや、それぞ
れ単独でアミノ酸や炭水化物と組合せて反応してもよい
。また、菌体を取得する時にこれらを添加しておいても
よい。The above culture solution or collected bacterial cells are suspended in 0.1 to 90%, preferably 0.2 to 0.5% as dry weight of the bacterial cells, in water or a buffer solution (pH 6 to 8) and reacted with hydrocarbons. and its derivatives from 1 to 70%, preferably from 10 to 30%
, L-glutamic acid, L-aspartic acid, or other amino acids, or glucose, citric acid, or other carbohydrates from 0.05 to
The basic reaction solution is one containing 10%, preferably 0.5 to 2%, and 0.001% of thiamin hydrochloride, etc.
~2%, preferably 0.01~0.0 as thiamin content.
The addition of 3% or 0.001 to 0.01% of inorganic metal salts such as magnesium sulfate and manganese sulfate is to significantly improve the productivity of unsaturated hydrocarbons and their derivatives.
Although combinations with amino acids such as glutamic acid and L-aspartic acid are preferred, they may also be reacted in combination with other carbohydrates or individually in combination with amino acids or carbohydrates. Further, these may be added at the time of obtaining the bacterial cells.
チアミンはソルトフリー、塩酸塩、硫酸塩等のいずれの
状態でもよい、無機金属塩としては硫酸マグネシウムが
好ましいが、硫酸マンガン等、硫酸または、マグネシウ
ムあるいはマンガンを含む無機金属塩も用いることがで
きる。Thiamine may be in any state such as salt-free, hydrochloride, sulfate, etc. The inorganic metal salt is preferably magnesium sulfate, but sulfuric acid, such as manganese sulfate, or inorganic metal salts containing magnesium or manganese can also be used.
また、アミノ酸、炭水化物、チアミン、無機金属塩等を
含む混合物として、天然物に由来するエキス類やアミノ
酸混合物、例えば、肉エキス、酵母エキス、カザミノ酸
等も添加して用いることができる。Furthermore, as a mixture containing amino acids, carbohydrates, thiamine, inorganic metal salts, etc., extracts derived from natural products and amino acid mixtures, such as meat extracts, yeast extracts, casamino acids, etc., can also be added and used.
反応時間は、回分反応を行う場合、1〜3日程度で良い
が、原料となる炭化水素及びその誘導体、この反応によ
り反応液中に加えた炭化水素及びその誘導体に対応する
不飽和炭化水素及びその誘導体が生成する。The reaction time may be about 1 to 3 days when performing a batch reaction, but the reaction time may be approximately 1 to 3 days, but the reaction time may be approximately 1 to 3 days, but the reaction time may be approximately 1 to 3 days. Derivatives thereof are produced.
反応液中に生成した不飽和炭化水素及びその誘導体の同
定、定量方法は、通常の天然物に含まれる有機化合物の
同定、定量方法により行われる。The unsaturated hydrocarbons and their derivatives produced in the reaction solution can be identified and quantified using conventional methods for identifying and quantifying organic compounds contained in natural products.
例えば、反応液の一定量より有機溶剤にて抽出を行った
後、ガスクロマトグラフィー(GC)あるいはガスクロ
マトグラフ・質量分析計(GC−MS)等による分析を
行うことにより、同定、定量することができる。不飽和
化合物の二重結合の位置決定には、例えば、ジメチルジ
スルフィド処理後、QC−MS分析を行うメチルチオエ
ーテル化法〔2原ら、油化学 34巻 619頁(19
85年)他]等が利用できる。For example, identification and quantification can be performed by extracting a certain amount of the reaction solution with an organic solvent and then analyzing it using gas chromatography (GC) or gas chromatograph/mass spectrometer (GC-MS). can. To determine the position of the double bond of an unsaturated compound, for example, a methylthioetherification method in which QC-MS analysis is performed after treatment with dimethyl disulfide [2 Hara et al., Oil Chemistry Vol. 34, p. 619 (19
1985) and others] are available.
反応液中に生成した不飽和炭化水素及びその誘導体は、
通常の天然物からの有機化合物の抽出・単離方法により
、回収・分離できる。例えば、反応液を遠心分離により
菌体、油層、水層に分は油ラムクロマトグラフィー、分
配抽出などにより精製・単離が可能である。The unsaturated hydrocarbons and their derivatives produced in the reaction solution are
It can be recovered and separated using ordinary methods for extracting and isolating organic compounds from natural products. For example, the reaction solution can be centrifuged to separate bacterial cells, an oil layer, and an aqueous layer, which can be purified and isolated by oil column chromatography, partition extraction, or the like.
本発明によれば、ロドコッカス属に属する不飽和炭化水
素生産菌の菌体を使用して不飽和炭化水素およびその誘
導体を工業的に有利に製造することができる。According to the present invention, unsaturated hydrocarbons and derivatives thereof can be industrially advantageously produced using cells of unsaturated hydrocarbon-producing bacteria belonging to the genus Rhodococcus.
次に実施例を挙げて説明する。 Next, an example will be given and explained.
実施例1
グルコース2.5g、ポリペプトン〔大玉栄養(株)製
〕17g、ポリペプトンS〔大玉栄養(株)製)3g、
リン酸2水素lカリウム2.5g、塩化ナトリウム5g
およびイオン交換水11よりなる培地50m1を入れた
5 00mj!容坂ロフラスコにロドコッカス・エスピ
ー・KSM−B−3M株を移植し、30゛Cにて1日間
振盪焙養を行った。後、この培養液1mlを同じ組成の
培地ナトリウム、0.1%チアミン塩酸塩、0.1%硫
酸マグネシウムを含む0.25Mリン酸緩衝液(pH7
,O)20mj!に懸濁し、n−へキサデカン5mlを
加え、500mj!容坂ロフラスコ中で30゛Cで2日
間振盪し反応を行った。Example 1 2.5 g of glucose, 17 g of polypeptone (manufactured by Otama Nutrition Co., Ltd.), 3 g of polypeptone S (manufactured by Otama Nutrition Co., Ltd.),
Dihydrogen phosphate l Potassium 2.5g, Sodium chloride 5g
500 mj containing 50 ml of culture medium consisting of ion exchange water and 11 ml of ion-exchanged water! Rhodococcus sp. KSM-B-3M strain was transplanted into a Yosaka Rof flask and incubated with shaking at 30°C for 1 day. After that, 1 ml of this culture solution was added to a 0.25 M phosphate buffer (pH 7) containing the same composition of medium sodium, 0.1% thiamine hydrochloride, and 0.1% magnesium sulfate.
,O)20mj! Suspend in 500 mj! and add 5 ml of n-hexadecane. The reaction was carried out by shaking in a Yosaka Lough flask at 30°C for 2 days.
反応後、反応液に含まれる主生成物を酢酸エチルで抽出
し、ガスクロマトグラフィー(GC)、ガスクロマトグ
ラフ・質量分析計(GC−MS)あるいはガスクロマト
グラフ・赤外分析計(GC−FT−TR)による分析を
行い(図1)、主生成物がシス−7−へキサデセン(c
is−7−hexadecene)であることを確認し
た。なお、二重結合の位置決定はジメチルジスルフィド
t 4体化後、マススペクトルの解析により行った(図
2)、主生成物のマススペクトルを図3に示した。After the reaction, the main product contained in the reaction solution is extracted with ethyl acetate and subjected to gas chromatography (GC), gas chromatograph/mass spectrometer (GC-MS), or gas chromatograph/infrared analyzer (GC-FT-TR). ) (Figure 1), and the main product was cis-7-hexadecene (c
is-7-hexadecene). The position of the double bond was determined by mass spectrum analysis after dimethyl disulfide t tetramerization (FIG. 2), and FIG. 3 shows the mass spectrum of the main product.
反応液1mff1を酢酸エチル3mlで抽出し、シス−
7−ヘキサデセンの量をガスクロマトグラフィーにより
測定したところ、18 g / l・2日の生産性であ
った。1 mff1 of the reaction solution was extracted with 3 ml of ethyl acetate, and cis-
When the amount of 7-hexadecene was measured by gas chromatography, the productivity was 18 g/l in 2 days.
decane) 、n−オクタデカン(n−octad
ecane)、n−エイコサン(n−eicosane
)、1−クロロ−テトラデカン(1−chloro−t
etradecane)、■−クロローヘキサデカン(
1−chloro−hexadecane) 、l−ク
ロローオクタデカン(1−chloro−octade
cane) 、あるいはl−クロロ−エイコサン(1−
chloro−eicosane)を用いた以外は実施
例1と同様の操作を行い、反応させた。decane), n-octadecane (n-octad
ecane), n-eicosane
), 1-chloro-tetradecane (1-chloro-t
ettradecane), ■-chlorohexadecane (
1-chloro-hexadecane), l-chloro-octadecane (1-chloro-octade)
cane), or l-chloro-eicosane (1-
The reaction was carried out in the same manner as in Example 1 except that chloro-eicosane was used.
反応液中の不飽和炭化水素またはその誘導体を実施例1
と同様の操作により同定・定量を行ったところ、下記表
−1に示す如き結果を得た。Example 1
Identification and quantification were performed in the same manner as above, and the results shown in Table 1 below were obtained.
以下余白
実施例3
一ヘプタデカノニトリル(n−heptadecano
nitorile)を用いた以外は実施例1と同様の操
作を行い、反応させた。Below is a blank space Example 3: One heptadecanonitrile (n-heptadecanonitrile)
The reaction was carried out in the same manner as in Example 1 except that nitorile) was used.
反応液中の不飽和炭化水素を実施例1と同様の操作によ
り同定・定量を行ったところ、下記表−2に示す如き結
果を得た。When the unsaturated hydrocarbons in the reaction solution were identified and quantified in the same manner as in Example 1, the results shown in Table 2 below were obtained.
以下余白
実施例4
実施例1のn−ヘキサデカンの代わりに1−へキサデセ
ン(1−hexadecene) 、1−オクタデセン
(1−octadecene)、1−エイコセン(1−
eicosene)、1−テトラデセン(1−te t
radecene)を用いた以外は実施例1.!:同様
の操作を行い、反応させた。Below is a blank space Example 4 In place of n-hexadecane in Example 1, 1-hexadecene (1-hexadecene), 1-octadecene (1-octadecene), 1-eicosene (1-
eicosene), 1-tetradecene (1-te t
Example 1 except that radecene) was used. ! : The same operation was performed to cause a reaction.
反応液中の不飽和炭化水素を実施例1と同様の操作によ
り同定・定■を行ったところ、下記表−比較例1
容坂ロフラスコにロドコッカス・エスピー・KSM−B
−3M株を移植し、30°Cにて1日間振盪培養を行っ
た。後、この培養液ImAを同じ組成の培地100mj
2を入れた5 00mff1容坂ロフラスコに移植し、
30°Cにて1日間振盪培養を行った。この培養液を5
000x工で遠心分離を行い菌体2gを得た。菌体1g
を1.0%グルコースを含む0.25Mリン酸緩衝FL
(pH7,0)20mj2に懸濁し、1−クロロ−ヘキ
サデカン4mβを加え、500ml容坂ロフラスコ中で
30°Cで2日間振盪し反応を行った。The unsaturated hydrocarbons in the reaction solution were identified and determined in the same manner as in Example 1.
-3M strain was transplanted and cultured with shaking at 30°C for 1 day. After that, this culture solution ImA was mixed with 100 mj of a medium of the same composition.
2 into a 500mff1 Yosaka flask,
Shaking culture was performed at 30°C for 1 day. Add this culture solution to 5
Centrifugation was performed at 000x to obtain 2 g of bacterial cells. 1g of bacterial cells
0.25M phosphate buffer FL containing 1.0% glucose
The suspension was suspended in 20mj2 (pH 7,0), 4mβ of 1-chloro-hexadecane was added, and the reaction was carried out by shaking in a 500ml Sakaro flask at 30°C for 2 days.
反応液1mfを酢酸エチル3mlで抽出し、1−クロロ
−へキサデセンの世を実施例1と同様の操作により同定
・定量を行ったところ、5.5g/l・2日間の生産性
であった。1 mf of the reaction solution was extracted with 3 ml of ethyl acetate, and 1-chloro-hexadecene was identified and quantified in the same manner as in Example 1, and the productivity was 5.5 g/l for 2 days. .
比較例2
比較例1の1.0%グルコースを含む0.25M Uン
酸緩衝液の代わりに1.0%L−グルタミン酸モノナト
リウムを含む0.25MIJン酸緩衝ころ、6.2g/
F!・2日間の生産性であった。Comparative Example 2 A 0.25MIJ acid buffer roller containing 1.0% L-glutamate monosodium instead of the 0.25M U acid buffer containing 1.0% glucose of Comparative Example 1, 6.2 g/
F!・It was productive for 2 days.
実施例5
比較例1の1.0%グルコースを含む0.25Mリン酸
緩衝液の代わりに
01.0%グルコース、0.1%チアミン塩酸塩を含む
0.25Mリン酸緩衝液、
■1.0%L−グルタミン酸モノナトリウム、硫酸マグ
ネシウムを含む0.25Mリン酸緩衝液、■1.0%L
−グルタミン酸モノナトリウム、0.1%チアミン塩酸
塩を含む0.25Mリン酸緩衝ンi、
■1.0%L−グルタミン酸モノナトリウム、0.1%
チアミン塩酸塩、0.1%硫酸マグネシウムを含む0.
25MIJン酸緩衝液、■1.0%L−アスパラギン酸
モノナトリウム、0.1%チアミン塩酸塩、0.1%硫
酸マグネシウムを含む0.25Mリン酸緩衝液、
■1.0%グリシンン、0.1%チアミン塩酸塩、0.
1%硫酸マグネシウムを含む0.25MIJン■1.0
%L−スレオニン、0.1%チアミン塩酸塩、0−11
%硫酸マグネシウムを含む0.25M IJン酸緩衝液
、
■1.0%L−プロリン、0.1%チアミン塩酸塩、0
.1%硫酸マグネシウムを含む0.25Mリン酸緩衝液
@1.0%L−グルタミン酸モノナトリウム、0.1%
硫酸マンガンを含む0.25M+Jン酸緩衝液をそれぞ
れ用いた以外は比較例1と同様の方法で反応させた。Example 5 0.25M phosphate buffer containing 01.0% glucose and 0.1% thiamine hydrochloride instead of the 0.25M phosphate buffer containing 1.0% glucose of Comparative Example 1, 1. 0.25M phosphate buffer containing 0% L-monosodium glutamate and magnesium sulfate, ■1.0%L
- Monosodium glutamate, 0.25M phosphate buffer containing 0.1% thiamine hydrochloride, ■ 1.0% L-monosodium glutamate, 0.1%
Thiamine hydrochloride, 0.1% magnesium sulfate.
25MIJ phosphate buffer, ■ 0.25M phosphate buffer containing 1.0% monosodium L-aspartate, 0.1% thiamine hydrochloride, 0.1% magnesium sulfate, ■ 1.0% glycine, 0 .1% thiamine hydrochloride, 0.
0.25 MIJ containing 1% magnesium sulfate 1.0
% L-Threonine, 0.1% Thiamine Hydrochloride, 0-11
0.25M IJ acid buffer containing % magnesium sulfate, ■ 1.0% L-proline, 0.1% thiamine hydrochloride, 0
.. 0.25M phosphate buffer containing 1% magnesium sulfate @ 1.0% monosodium L-glutamate, 0.1%
The reaction was carried out in the same manner as in Comparative Example 1, except that 0.25M+J acid buffer containing manganese sulfate was used.
反応液中の1−クロロ−へキサデセンを実施例1と同様
の操作により同定・定量を行ったところ、下記表−4に
示す如き結果を得た。When 1-chloro-hexadecene in the reaction solution was identified and quantified in the same manner as in Example 1, the results shown in Table 4 below were obtained.
以下余白
参考例1
採取した沖縄具の土壌サンプル約0.5gを滅菌水10
mffに懸濁し、充分攪拌後、この懸濁液0.2mff
1を下記組成の液体培地(1) 10mjl!(試験管
φ25X200mm)に接種し、30゛Cで4日間振盪
培養を行った。Reference example 1: Approximately 0.5g of the soil sample collected from Okinawa was added to 100ml of sterilized water.
After stirring thoroughly, 0.2 mff of this suspension was added.
1 into a liquid medium (1) with the following composition: 10 mjl! (Test tube φ25 x 200 mm) was inoculated and cultured with shaking at 30°C for 4 days.
Kll□p0420 g
酵母エキス 2g
Mg5Oa −TIIZOQ、5 g
Peso、 = 711.0 0.01
gMnSO4・4〜6tlz0 0.008
gイオン交換水 12
pH7
上記培養により増殖を示した培養液を滅菌水により適度
に希釈した後、普通寒天培地(栄研化学製)に移植して
30°Cにて2日間培養し、生じた複数のコロニーが相
互間に相違しないことを肉眼的および顕微鏡的に確認で
きるまで、普通寒天培地への移植を操り返した。Kll□p0420 g Yeast extract 2 g Mg5Oa -TIIZOQ, 5 g Peso, = 711.0 0.01
gMnSO4・4~6tlz0 0.008
g Ion-exchanged water 12 pH 7 After diluting the culture solution that showed growth from the above culture with sterilized water, it was transferred to an ordinary agar medium (manufactured by Eiken Chemical Co., Ltd.) and cultured at 30°C for 2 days. Transfers to plain agar plates were repeated until it was confirmed macroscopically and microscopically that the colonies were not different from each other.
本分離菌株をO,IMリン酸緩衝i!(pH7,0)に
懸濁し、紫外線を90秒間照射した。This isolated strain was transferred to O, IM phosphate buffer i! (pH 7.0) and irradiated with ultraviolet light for 90 seconds.
そのあと取得したコロニーをグルコース2.5g、ポリ
ペプトン17g1ポリペプトン33g、リン酸2水素1
カリウム2.5g、塩化ナトリウム5gおよびイオン交
換水12よりなる培地50m1を入れた5 00mj2
容坂ロフラスコに移植し、19m2に懸濁し、ヘキサデ
カン1mj2を加え、500mj!容坂ロフラスコ中で
30°Cで3日間振盪した。 振盪後、反応液に含まれ
る主生成物を抽出し、ガスクロマトグラフィー(GC)
等による分析を行い、ヘキサデセンを生産する菌株につ
いて取得した。After that, the obtained colonies were combined with 2.5 g of glucose, 17 g of polypeptone, 33 g of polypeptone, and 1 g of dihydrogen phosphate.
500 mj2 containing 50 ml of a medium consisting of 2.5 g of potassium, 5 g of sodium chloride, and 12 g of ion-exchanged water.
Transplanted to Yosaka Lough flask, suspended in 19 m2, added 1 mj2 of hexadecane, and 500 mj! Shake at 30°C for 3 days in a Yosaka Lough flask. After shaking, the main product contained in the reaction solution was extracted and subjected to gas chromatography (GC).
We obtained strains that produce hexadecene.
このヘキサデセンを生産する菌株を滅菌水により適度に
希釈した後、普通寒天培地に移植して30°Cにて2日
間培養し、生じた複数のコロニーその後、普通寒天培地
に生育してきたコロニーノウチ、10個のコロニーをそ
れぞれ、下記組成の斜面寒天培地(U)に接種し、30
°Cにて3日間培養し、10本の斜面寒天培地上の菌株
が肉眼的および顕微鏡的に同−菌株であること、および
これら10菌株の各培地とでの性状および生理学的性質
が同一であることを確認した。After appropriately diluting this hexadecene-producing strain with sterilized water, it was transplanted onto an ordinary agar medium and cultured at 30°C for 2 days, resulting in multiple colonies that had grown on the ordinary agar medium. Ten colonies were each inoculated onto a slanted agar medium (U) with the following composition, and 30
After culturing at °C for 3 days, it was confirmed that the strains on the 10 slanted agar plates were macroscopically and microscopically the same strain, and that the properties and physiological properties of these 10 strains were the same on each medium. I confirmed that there is.
斜面寒天培地(■):
n−ヘキサデカン 20 g
(Ni14)zsO420g
KlhPO42g
酵母エキス 2g
Mg5Oa・ 7i120 0.5 gF
eSOa −7HzOO,01g
MnSOn ・4〜6HzO0,008gポリオキシエ
チレン−
ソルビタンモノラウリン酸 0.05 gエステル(
平均付加EO数 20モル)寒天
20 g
イオン交換水 11
リセリン水溶液(2mff)の入った凍結保存用のバイ
アルに懸濁し一80゛Cにて凍結保存した。Slanted agar medium (■): n-hexadecane 20 g (Ni14)zsO420g KlhPO42g Yeast extract 2g Mg5Oa・7i120 0.5 gF
eSOa -7HzOO,01g MnSOn 4-6HzO0,008g polyoxyethylene- Sorbitan monolauric acid 0.05g ester (
Average number of added EOs: 20 moles) Agar
20 g ion-exchanged water 11 The suspension was suspended in a cryopreservation vial containing an aqueous lyserin solution (2 mff) and stored frozen at -80°C.
斯くして3ケ月保存後、迅速に解凍して得られる懸濁液
の一白金耳を寒天培地で蘇生後、前記と同条件下に各培
地上での性状および生理学的性質を調べた結果、変化が
ないことを確認した。After 3 months of storage, a loopful of the suspension obtained by rapid thawing was resuscitated on an agar medium, and the properties and physiological properties were examined on each medium under the same conditions as above. I confirmed that there was no change.
また、上記凍結および解凍を1ケ月毎に5回繰り返した
菌株に就いても、同様に各培地上での性状および生理学
的性質を調べたが、変化は認められなかった。Furthermore, the properties and physiological properties of the bacterial strains that had been subjected to the above freezing and thawing process repeated five times every month were examined in the same manner on each medium, but no changes were observed.
なお、本菌株の各培地上での性状および生理学的性質は
前述したとおりである。The properties and physiological properties of this strain on each medium are as described above.
図1に本発明により製造したシス−ヘキサデセンのGC
−FT−I Hによるスペクトルを示した。
図2に本発明により製造したシス−ヘキサデセンのビス
メチルチオエーテル誘導体のマススペクトルを示した。
図3に本発明により製造したシス−ヘキサデセンのマス
スペクトルを示した。
以上Figure 1 shows GC of cis-hexadecene produced according to the present invention.
-FT-I H spectra are shown. FIG. 2 shows a mass spectrum of the bismethylthioether derivative of cis-hexadecene produced according to the present invention. FIG. 3 shows the mass spectrum of cis-hexadecene produced according to the present invention. that's all
Claims (1)
体を用い、炭水化物もしくはアミノ酸存在下に、炭化水
素またはその誘導体を該菌体に作用せしめ不飽和炭化水
素またはその誘導体を製造するに際し、系内にチアミン
または無機金属塩を存在させることを特徴とする不飽和
炭化水素およびその誘導体の製造法。 2、不飽和炭化水素生産菌がロドコッカス・エスピー・
KSM−B−3M株である特許請求の範囲第1項記載の
製造法。 3、炭水化物がグルコース、ソルビトール、アラビノー
ス、キシロース、フラクトース、イノシトール、ラムノ
ース、マンニトール、酢酸、コハク酸、クエン酸である
特許請求の範囲第1項記載の製造法。 4、アミノ酸がL−グルタミン酸、L−アスパラギン酸
、グリシン、L−スレオニン、L−チロシン、L−イソ
ロイシン、L−プロリンである特許請求の範囲第1項記
載の製造法。 5、無機金属塩が、硫酸またはマグネシウムあるいはマ
ンガンを含む無機金属塩である特許請求の範囲第1項記
載の製造法。 6、炭化水素またはその誘導体がn−ドデカン、n−ヘ
プタデカン、n−ヘキサデカン、n−オクタデカン、n
−テトラデカン、n−ペンタデカン、n−エイコサン、
クロロ−ヘプタデカン、クロロ−ヘキサデカン、クロロ
−オクタデカン、ヘキサデシルアルコール、ヘキサデシ
ルベンゼン、ヘプタデカノニトリル、ヘキサデセン、エ
イコセン、オクタデセン、テトラデセンからなる群より
選ばれたものである第1項記載の製造法。[Claims] 1. Using the cells of an unsaturated hydrocarbon-producing bacterium belonging to the genus Rhodococcus, hydrocarbons or derivatives thereof are applied to the cells in the presence of carbohydrates or amino acids to produce unsaturated hydrocarbons or derivatives thereof. 1. A method for producing unsaturated hydrocarbons and derivatives thereof, characterized in that thiamine or an inorganic metal salt is present in the system. 2. The unsaturated hydrocarbon-producing bacterium is Rhodococcus sp.
The production method according to claim 1, which is the KSM-B-3M strain. 3. The production method according to claim 1, wherein the carbohydrate is glucose, sorbitol, arabinose, xylose, fructose, inositol, rhamnose, mannitol, acetic acid, succinic acid, or citric acid. 4. The production method according to claim 1, wherein the amino acids are L-glutamic acid, L-aspartic acid, glycine, L-threonine, L-tyrosine, L-isoleucine, and L-proline. 5. The production method according to claim 1, wherein the inorganic metal salt is an inorganic metal salt containing sulfuric acid, magnesium, or manganese. 6. The hydrocarbon or its derivative is n-dodecane, n-heptadecane, n-hexadecane, n-octadecane, n-
-tetradecane, n-pentadecane, n-eicosane,
2. The method according to claim 1, wherein the compound is selected from the group consisting of chloro-heptadecane, chloro-hexadecane, chloro-octadecane, hexadecyl alcohol, hexadecylbenzene, heptadecanonitrile, hexadecene, eicosene, octadecene, and tetradecene.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30005887A JPH01144983A (en) | 1987-11-30 | 1987-11-30 | Production of unsaturated hydrocarbon and derivative thereof |
EP88308091A EP0319123B1 (en) | 1987-11-30 | 1988-09-01 | Process for producing unsaturated fatty acid or unsaturated hydrocarbon |
DE3853807T DE3853807T2 (en) | 1987-11-30 | 1988-09-01 | Process for the production of unsaturated fatty acids or unsaturated hydrocarbons. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30005887A JPH01144983A (en) | 1987-11-30 | 1987-11-30 | Production of unsaturated hydrocarbon and derivative thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH01144983A true JPH01144983A (en) | 1989-06-07 |
JPH028715B2 JPH028715B2 (en) | 1990-02-26 |
Family
ID=17880190
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30005887A Granted JPH01144983A (en) | 1987-11-30 | 1987-11-30 | Production of unsaturated hydrocarbon and derivative thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01144983A (en) |
-
1987
- 1987-11-30 JP JP30005887A patent/JPH01144983A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPH028715B2 (en) | 1990-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5356812A (en) | Processes for production of optically active 3-phenyl-1,3-propanediol by asymmetric assimilation | |
JPH0516833B2 (en) | ||
EP0000560A1 (en) | Process for the preparation of optically active alpha-hydroxycarboxylic acids | |
US5059532A (en) | Microorganism belonging to genus Rhodococcus, and a process for producing alkene derivative and unsaturated fatty acid | |
JPH01144983A (en) | Production of unsaturated hydrocarbon and derivative thereof | |
EP0319123B1 (en) | Process for producing unsaturated fatty acid or unsaturated hydrocarbon | |
US4840907A (en) | Process for producing optically active dichloropropanol using microorganism | |
EP0089039B1 (en) | Process for producing d-beta-hydroxyalkanoic acid | |
JPH0412718B2 (en) | ||
US4613571A (en) | Polyprenyl sulfone derivatives and process for producing the same | |
JPS63202392A (en) | Production of unsaturated fatty acid and derivative thereof | |
JPH048039B2 (en) | ||
JP3387554B2 (en) | Method for producing canthaxanthin | |
JPS58155093A (en) | Microbiological production of l-carbon | |
GB2160866A (en) | Preparing 2-arylpropionic acids | |
JPS63202373A (en) | Novel microorganism | |
JP2563074B2 (en) | Process for producing natural β-phenethyl alcohol | |
JP2797295B2 (en) | Novel microorganism and method for producing menaquinone-4 using the novel microorganism | |
JPS6316119B2 (en) | ||
FR2528868A1 (en) | PROCESS FOR THE PREPARATION OF L-LEUCINE BY FERMENTATION | |
JPS63202388A (en) | Production of alkene derivative | |
JPH08196288A (en) | Production of long-chain fatty acid | |
FR2555198A1 (en) | METHOD FOR ENHANCING A MICROORGANISM STRAIN FOR THE PREPARATION OF L-SERINE BY FERMENTATION AND THE STRAIN OBTAINED | |
JPH06253891A (en) | Production of (r)-alpha-methylbenzylamine | |
JPS6319153B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EXPY | Cancellation because of completion of term |